|
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes
|
1R01CA216265-01
|
$632,860
|
CHRISTENSEN, BROCK
|
DARTMOUTH COLLEGE
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
402 -- A PHASE I TRIAL OF THE SAFETY IMMUNOGENICITY OF RG1-VLP... (PROTOCOL UWI2016-08-02). CONTRACTOR: UNIVERSITY OF WISCONSIN. CONTRACT NO: HHSN261201200033I, TASK ORDER: HHSN261000012. FROM 9/1
|
261201200033I
|
$1,485,915
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$339,315
|
Barchi, Joseph
|
CCR (NCI)
|
|
A Phase I Combination Study of Durvalumab and Vicinium in BCG refractory NMIBC
|
ZIA BC 011786
|
$32,548
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillu
|
ZIA BC 011528
|
$97,645
|
Agarwal, Piyush
|
CCR (NCI)
|
|
AARP Collaborative Environmental Projects
|
ZIA CP010125 10824
|
$28,500
|
Jones, Rena
|
DCEG (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 03152
|
$477,453
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$703,174
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$703,174
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
|
5U24CA180921-05
|
$705,863
|
BECICH, MICHAEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Ambient dioxin exposure and cancer risk in women (IWHS and AHS)
|
ZIA CP010125 10712
|
$40,865
|
Jones, Rena
|
DCEG (NCI)
|
|
Analyzing Complex Cancer Studies With Skewed Responses
|
5R03CA205018-02
|
$83,299
|
LIPSITZ, STUART
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
Barr, Frederic
|
CCR (NCI)
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,161,432
|
N/A
|
DCEG (NCI)
|
|
Bayesian methods for complex, high-dimensional functional data in cancer research
|
5R01CA178744-03
|
$358,240
|
MORRIS, JEFFREY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
BCDDP: Breast cancer detection demonstration project followup study - I
|
ZIA CP010182 01030
|
$6,159
|
Schairer, Catherine
|
DCEG (NCI)
|
|
BCG therapy of bladder cancer: the role of BCG uptake by bladder cancer cells
|
5K08CA184038-04
|
$177,660
|
REDELMAN-SIDI, GIL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Biomarkers for Staging and Treatment Response Monitoring of Bladder Cancer
|
5U01CA179106-04
|
$548,074
|
HADJIYSKI, LUBOMIR
|
UNIVERSITY OF MICHIGAN
|
|
Biomarkers of human papillomavirus (HPV) infection and risk of two increasing cancers
|
5U01CA195603-03
|
$466,874
|
BRENNAN, PAUL
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
Bladder Cancer GWAS
|
ZIA CP010187-10461
|
$22,955
|
Rothman, Nat
|
DCEG (NCI)
|
|
Bladder cancer in the Northeastern U.S.
|
ZIA CP010125-02212
|
$409,947
|
Silverman, Debra
|
DCEG (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$357,695
|
Apolo, Andrea
|
CCR (NCI)
|
|
BRCA Challenge Tools
|
ZIH CP010205 10746
|
$43,606
|
Hoover, Robert
|
DCEG (NCI)
|
|
Breast and other cancers following x-rays for scoliosis
|
ZIA CP010222 04150
|
$22,134
|
Kitahara, Cari
|
DCEG (NCI)
|
|
Breast cancer among a DDT exposed population in Triana, AL
|
ZIA CP010123 02365
|
$94,821
|
Hoover, Robert
|
DCEG (NCI)
|
|
Breast cancer in Asian-American women
|
ZIA CP010169 03030
|
$274,191
|
Ziegler, Regina
|
DCEG (NCI)
|
|
Breast Cancer Methylation Project
|
ZIA CP010126 10752
|
$3,086
|
Garcia-Closas, Montserrat
|
DCEG (NCI)
|
|
Breast cancer risk model development and validation
|
ZIA CP010126 10753
|
$212,637
|
Garcia-Closas, Montserrat
|
DCEG (NCI)
|
|
Breast cancer risk prediction: Development of a new model including mammographic
|
ZIA CP010188 00318
|
$48,047
|
Gail, Mitchell
|
DCEG (NCI)
|
|
Breast Cancer Studies in Africa
|
ZIA CP000185 10778
|
$31,496
|
Dawsey, Sandy
|
DCEG (NCI)
|
|
Breast imaging studies in women at high genetic risk of breast cancer
|
ZIA CP010145 07040
|
$407,935
|
Loud, Jennifer
|
DCEG (NCI)
|
|
Breast implant follow-up study
|
ZIA CP010128 01220
|
$14,330
|
Hoover, Robert
|
DCEG (NCI)
|
|
BREAST Stamp Project
|
ZIA CP010126 10368
|
$43,829
|
Benson, Gretchen
|
DCEG (NCI)
|
|
Building sustainable and innovative research in Cancer and Cardiovascular disease: Planning the design and development of the South American Center of Research Excellence to Counter NCDs (SACREN)
|
1P20CA217231-01
|
$249,500
|
Irazola, Vilma
|
INSTITUTO DE EFECTIVIDAD CLINICA Y SANIT
|
|
Building upon a tradition of excellence. The NCTN at Indiana University
|
5U10CA180795-04
|
$519,002
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133 04180
|
$145,295
|
Linet, Martha
|
DCEG (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|